Evandro de Azambuja

45PUBLICATIONS
209CO-AUTHORS
Molecular targetsPredictive and prognostic markersFood properties (incl. characteristics and health benefits)Cancer therapy (excl. chemotherapy and radiation therapy)Environmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Jul 10, 2026
EVERolimus effectiveness after proGREssion on ENdocrine therapy plus CDK4/6 inhibitor for ER-positive/HER2-negative advanced breast cancer: EVERGREEN study.

|Jan 21, 2026
Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer.

Sara M Tolaney, Evandro de Azambuja, Kevin Kalinsky

|Jun 13, 2025
Association of HER2-low with clinicopathological features in patients with early invasive lobular breast cancer: an international multicentric study.

Karen Van Baelen, Ha-Linh Nguyen, François Richard

|Apr 28, 2025
Impact of Dietary Supplements on Clinical Outcomes and Quality of Life in Patients with Breast Cancer: A Systematic Review.

Luca Scafuri, Carlo Buonerba, Oriana Strianese

|Sep 11, 2024
Adjuvant Pertuzumab and Trastuzumab in Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the APHINITY Trial: Third Interim Overall Survival Analysis With Efficacy Update.

Sibylle Loibl, Jacek Jassem, Amir Sonnenblick

|Jun 24, 2024
Current practices in oncofertility counseling: updated evidence on fertility preservation and post-treatment pregnancies in young women affected by early breast cancer.

Luca Arecco, Roberto Borea, Isotta Martha Magaton

Pageof 8

Frequent Collaborators

9 joint publications

Martine Piccart-Gebhart

9 joint publications

Matteo Lambertini

6 joint publications

Diogo Martins-Branco

6 joint publications

Mariana Brandão